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Introduction
The 28th European Respiratory Society (ERS) International 
Congress [2018] in Paris features interesting research 
findings within the allied respiratory professional assembly 
(assembly 9). Excellent and high ranked abstracts were 
selected for this year’s ERS International Congress preview 
of assembly 9 and are put in the spotlights. A summary 
of the best three abstracts of every group, i.e., lung 
function technologists, physiotherapists and nurses, within 
assembly 9 is presented. Session, timing and location of the 
presentation of the abstract at this year’s ERS International 
Congress is indicated in squared brackets following the 
authors’ name. 
Group 9.1: lung function technologists
Lung clearance index versus spirometry in children with 
cystic fibrosis taking lumacaftor/ivacaftor
There are two common pulmonary function tests to 
measure the lung function of the paediatric population 
who live with cystic fibrosis (CF); spirometry and multiple 
breath washout (MBW). MBW is able to present multiple 
different measures of lung efficiency and disease severity, 
the lung clearance index (LCI) has become the most used 
measure derived from MBW (1). The MBW tends to be a 
preferable measure for the paediatric CF population; tidal 
volume breathing makes it feasible to perform, the gasses 
inhaled are inert, and the gasses used do not participate in 
any gas exchange within the lungs (2). LCI has been shown 
in studies to be a more sensitive measurement for paediatric 
CF than spirometry alone (3). The data being presented 
by Mulligan et al. (Sunday 16 September, 08:30–10:30 AM, 
Room 7.3P) is consistent with previous studies in sensitivity 
changes between spirometry and LCI, as seen pre and post 
lumacaftor/ivacaftor delivery (Table 1).
There is a large utility for LCI in the paediatric CF 
population when combined with spirometry (4). Clinically 
LCI is important to assess the need for treatment, the 
severity of disease, and outcomes of therapies. In a research 
context, LCI should be included in study design for safety, 
especially in research that involves CF populations. While 
the importance of forced expiratory volume at one second 
(FEV1) should not be dismissed, LCI is more sensitive and 
helps to complete the diagnostic picture.
Development and pilot evaluation of a quality grading 
system for paediatric spirometry
ATS/ERS has established standard spirometry guidelines 
for adult populations for years now, but paediatric patients 
present different challenges that have made this form of 
standardization slower to progress (5). Understanding 
the need to start this process, Perrem et al. (Tuesday 18 
September, 10:45 AM –12:45 PM, Room 7.3B) have set out 
to independently begin creating a model to grade paediatric 
Editorial
European Respiratory Society International Congress best abstract 
preview from the allied respiratory professionals from assembly 9 
Jason Blonshine1#, Joana Cruz2,3#, Andreja Sajnic4#, Jana De Brandt5
1TechEd Consultants, Inc., Metatec, Michigan USA; 2Center for Innovative Care and Health Technology (ciTechCare), Polytechnic Institute of 
Leiria, Leiria, Portugal; 3Respiratory Research and Rehabilitation Laboratory (Lab3R), School of Health Sciences, University of Aveiro, Aveiro, 
Portugal; 4Department for Respiratory Diseases “Jordanovac”, University Hospital Center, Zagreb, Croatia; 5REVAL - Rehabilitation Research 
Center, BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium
#These authors contributed equally to this work.
Correspondence to: Jana De Brandt. Campus Diepenbeek, Hasselt University, Agoralaan Building A, 3590 Diepenbeek, Belgium.  
Email: jana.debrandt@uhasselt.be.
Submitted Jul 15, 2018. Accepted for publication Jul 17, 2018.
doi: 10.21037/jtd.2018.08.24
View this article at: http://dx.doi.org/10.21037/jtd.2018.08.24
3016
S3011Journal of Thoracic Disease, Vol 10, Suppl 25 September 2018
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(Suppl 25):S3010-S3016jtd.amegroups.com
spirometry; forced vital capacity (FVC) and FEV1.
The creation of a standard grading system is needed 
and important for the paediatric population. We know this 
already increases the quality and consistency of testing 
individually and between technologist, laboratories, and 
equipment manufacturers (6). Clinically, having standards 
to adhere to may have a direct impact on the quality 
interpretation. Without standards to address acceptability 
and repeatability before interpretation, quality, accuracy, 
and precision are sacrificed. The same impact should be 
simulated in research; quality and standardization of testing 
is paramount to facilitate a consistent evaluation of subject 
data. Criteria was generated after careful literature review 
in addition to expert opinion, FEV1 and FVC were both 
graded. Perrem et al. were able to maintain a high level of 
repeatability, acceptability, and agreement (91% for FEV1 
and 81% for FVC) in review between pulmonologist, 
respiratory scientists, and technologists. It is important to 
note that if disagreement existed between reviewers that 
the most experienced technologist was used as the “gold 
standard”. This is a very exciting start for a paediatric 
spirometry quality grading system and standardization, 
further research should be encouraged to help continue this 
important development.
The impact of a new reference value set for diffusing 
capacity for patients with idiopathic pulmonary fibrosis
The Global Lung Function Initiative (GLI) has created 
new reference values (7). The change of reference values 
from the 1993 coal reference values (8) to the GLI 
reference values cannot be taken lightly, as this impacts 
interpretation of new results and comparison to historical 
values. Wapenaar-De Korver et al. (Tuesday 18 September, 
10:45 AM –12.45 PM, Room 7.3B) have taken an important 
step for us to understand how this change can impact 
TLCO interpretation and research inclusion in idiopathic 
pulmonary fibrosis (IPF) patients. GLI reference values 
for TLCO are new and aim to provide a better reference 
set to be used in clinical practice, with data inclusion from 
19 centres across 14 countries it seems that there is an all-
age reference set (7). Lung function is a critical part of 
evaluating the respiratory system, thus having a standard 
set of reference values will aid in diagnosis of disease and 
health. Results show a slight increase in TLCO across 
145 patients, based on using the GLI reference values 
for TLCO the researchers noted 96 patients would be 
eligible using European Community for Steel and Coal 
(ECSC) reference values and 104 using GLI. While slight, 
the increase should be noted in both clinical and research 
environments. Clinically pulmonary groups should be 
careful not to make decisions on small improvements for 
the IPF patient, a change in reference value can be the only 
reason an improvement is seen versus an improvement in 
condition. Special care should be taken to communicate 
these important changes to physician groups to avoid 
miss interpretation. IPF has no current cure, creating 
opportunity for research and inclusion. When selecting 
reference values researchers should take note of the slight 
potential increase in inclusion if a DLCO ≥30% is used as 
criteria. While a slight increase in patients may be seen as 
small in a pharmaceutical study, it may actually be a very 
significant improvement when considering the severity and 
cost of researching new treatments for IPF.
Group 9.2: physiotherapists
Effects of a home-based rehabilitation programme in 
patients at active treatment for inoperable lung cancer
Lung cancer is among the most prevalent cancers and a 
major cause of cancer mortality worldwide (9). Non-small 
cell lung cancer (NSCLC) accounts for 80% of all lung 
cancers (10) and due to a lack of early specific symptoms, 
patients are often diagnosed at an advanced stage and 
present with inoperable disease (11). Therefore, prolonging 
Table 1 Effect of lumacaftor/ivacaftor intervention
Lumacaftor/ivacaftor intervention Pre-lumacaftor/ivacaftor Post-lumacaftor/ivacaftor
LCI, median (range) 11.25 (7.41–14.33) 8.32 (7.73–13.45)
ppFEV1 (%), median (range) 82.5 (49.5–103.0) 86.8 (48.5–106.5)
LCI, mean ± SD 11.14±2.30 9.41±2.35
ppFEV1 (%), mean ± SD 79.6±17.4 81.1±21.6
LCI, lung clearance index; pp, percent predicted; FEV1, forced expired volume at one second; SD, standard deviation.
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life and/or improving health-related quality of life (HRQoL) 
of these patients are the main goals of cancer treatment. 
Exercise interventions have been shown to prevent 
deterioration in physical status, improve exercise capacity 
and muscle strength, reduce fatigue and enhance HRQoL 
in patients with advanced cancer (12). In advanced NSCLC, 
there is still a limited number of randomised controlled 
trials (RCT) assessing the impact of exercise interventions 
and most of them are hospital-based (12). Although the 
ideal setting to implement exercise interventions in NSCLC 
is still under debate (13), home-based interventions have 
the potential to reduce patient burden associated with 
travel, improve patients’ adherence to the intervention 
and promote long-term behaviour change (14). Edbrooke 
et al. (Wednesday 19 September, 08:30–10:30 AM, Room 
7.3O) conducted a multicentre RCT which investigated 
the efficacy of a home-based multidisciplinary exercise 
and supportive care intervention versus standard care in 
patients starting active treatment for inoperable NSCLC. 
Patients in the experimental group (EG, n=45) received 
8 weeks of aerobic and resistance exercise, behaviour change 
and symptom management telephone support, in addition 
to standard care. The control group (CG, n=47) received 
standard care only which did not include any form of 
exercise training. The study protocol is described in detail 
elsewhere (15). Patients were assessed at 9 weeks (post-
intervention) and 6 months (follow-up). No significant 
between-group differences were found in physical function 
outcomes [6MWD (primary outcome), muscle strength and 
PA], which suggests that a home-based exercise intervention 
does not provide additional benefit to physical status 
compared to usual care in patients starting active treatment 
for inoperable NSCLC. While this is a disappointing 
finding, significant improvements were found in HRQoL 
(P=0.005), symptom severity (P=0.001) and exercise 
motivation (P=0.04) in the EG at 6-month follow-up. The 
fact that the intervention led to a decrease in symptom 
severity and an increase in HRQoL is an important 
outcome, since the usual pattern seen in patients living with 
advanced cancer is an increase in symptom burden which 
greatly interferes with patients’ HRQoL (11). Moreover, 
exercise motivation was significantly improved in the 
EG at follow-up. High exercise motivation was recently 
identified as one of the most prominent predictors of 
adherence to exercise-based interventions in patients 
with cancer (14). This finding suggests that the home-
based exercise intervention implemented by Edbrooke 
et al. may help patients being more physically active in 
the long-term.
Impact of a web-based physical activity enhancing 
intervention during pulmonary rehabilitation in COPD
Physical activity, which includes physical exercise, is 
reduced in patients with chronic obstructive pulmonary 
disease (COPD) when compared to healthy individuals (16). 
Low levels of PA have been associated with poor outcomes, 
including increased risk of exacerbations (17), hospital 
admissions and mortality (18). Thus, increasing patients’ 
PA levels has been identified as a priority for researchers 
and clinicians worldwide (19,20). Pulmonary rehabilitation 
(PR) is the cornerstone of COPD management with 
worldwide known benefits on patients’ exercise capacity and 
HRQoL (21). As such, and because it includes components 
of exercise training, education and behaviour change, it 
would be expected to have a positive effect on patients’ PA 
behaviour (19,21). However, studies assessing the impact of 
PR on PA have shown that an increase in exercise capacity 
does not necessarily translate into meaningful improvements 
in patients’ PA (22). Alternative methods to produce PA 
behaviour change are therefore needed. A recent systematic 
review on interventions aiming at increasing PA in patients 
with COPD has found that interventions including PA 
counselling and coaching, especially if combined with 
exercise training, are promising and should be further 
explored (22). Mantoani et al. (Monday 17 September, 
08:30–10:30 AM, Terminal 7) investigated the impact of 
a web-based PA enhancing intervention on PA levels of 
patients attending a 12-week PR programme. Patients with 
COPD were randomised to either receive a PA enhancing 
intervention during PR (experimental group, EG=22) or 
PR alone (control group, CG=22). The PA enhancing 
intervention consisted of a web-based PA human coaching 
with weekly individualised targets and objective feedback on 
patients’ PA measured by an activity monitor (TracmorD, 
Philips). Patients were assessed at baseline and after 
3 months. Findings suggest that the web-based PA 
enhancing intervention is effective in enhancing patients’ 
PA levels during PR when compared to PR alone 
(1,251±2,408 vs. −410±1,118 steps/day, respectively). The 
authors also found significant improvements (favouring 
the EG) in patients’ exercise capacity, quadriceps muscle 
strength, symptoms of anxiety and depression, and 
HRQoL, which further supports the idea that a more 
active lifestyle may translate into health benefits for 
these patients. These are exciting findings which may 
guide future interventions on PA promotion in COPD. 
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Since information and communication technologies 
are embedded in people’s everyday lives, the use of 
e-health interventions (e.g., websites) for PA promotion 
offer the opportunity to deliver personalised coaching 
to patients  with l imited healthcare resource use, 
facilitate self-management and reach a large proportion 
of people thereby reducing access disparities (23). 
Further research with follow-up assessments is needed to 
support these findings and assess the long-term impact of 
this web-based PA enhancing intervention in COPD, since 
maintenance of PA behaviour is a major challenge (24).
Predictors of patients’ completion or response to a 
12-month physical activity intervention in COPD
Previous research has shown that, as a complex behaviour, 
PA is influenced by a combination of factors including 
individual characteristics, disease-specific factors, 
psychosocial and environmental factors (19,20,25,26), that 
may act as barriers or facilitators. However, the extent to 
which these factors determine long-term maintenance 
of PA behaviour [which may be different from those 
involved in behaviour initiation (27)] remains understudied. 
The study of Koreny et al. (Monday 17 September, 
08:30–10:30 AM, Terminal 7) aimed to identify baseline 
predictors of 12-month completion or response to a PA 
enhancing intervention in patients with COPD, using 
logistic multivariable regressions. The authors identified 
‘completers’ (i.e., patients attending the final visit) and 
‘responders’ (i.e., patients who increased ≥600 steps/day 
after 12 months when compared to baseline, measured by 
an accelerometer) of the intervention arm of the Urban 
Training study (NCT01897298) and investigated the 
factors that predicted patients’ completion or response 
to the intervention. The authors found that ‘completers’ 
(n=132/202) were more likely to live with a partner, live 
in less disadvantaged neighbourhoods and be already 
physically active at baseline (≥10,000 steps/day) than ‘non-
completers’. From those who completed the study, 36% 
(n=47) were classified as ‘responders’. The odds of being 
a ‘responder’ were 2.7 times higher in patients currently 
working and those with an endocrino-metabolic disease 
than in ‘non-responders’. These findings suggest that 
although the decline in patients’ PA levels over time 
can be determined, in part, by COPD-related factors 
[e.g., exercise capacity (28)], they do not seem to play 
a role in maintaining PA behaviour during a 12-month 
intervention. Instead, factors related to patients’ living 
context and comorbidities may be associated with long-
term maintenance of active lifestyles. It is important to note 
that, despite the factors identified in the study of Koreny 
et al. may be regarded as nonmodifiable, they could be used 
to identify patients with low probability of engaging in 
and/or maintaining PA behaviour and develop additional 
strategies to reinforce this behaviour (24). Given the 
public health importance of promoting the adoption 
and maintenance of PA by patients with COPD, further 
research is needed to confirm these findings and identify 
other factors that may influence patients’ PA behaviour in 
the long-term. 
Group 9.3: nurses
Effectiveness of a hand-held fan for managing dyspnoea in 
patients with interstitial lung disease
Interstitial lung disease (ILD) is a diverse group of diseases 
that cause fibrosis or inflammation of the pulmonary 
parenchyma. Treatment and prognosis of ILD typically 
depends on the underlying ILD subtype, highlighting the 
importance of accurate classification and diagnosis (29). 
Breathlessness is a debilitating feature of ILD (30). Patients 
with chronic pulmonary disease are often limited in 
their activities by respiratory discomfort. Reductions in 
functional status, quality of life, and disability are frequent 
consequences of this symptom. Dyspnoea is a term used to 
characterize a subjective experience of breathing discomfort 
that consists of qualitatively distinct sensations that vary 
in intensity. The experience derives from interactions 
among multiple physiological, psychological, social, 
and environmental factors, and may induce secondary 
physiological and behavioural responses (31). Research 
from Galbraith et al. suggests that a hand-held fan that 
generates airflow over the face can reduce the sensation 
of breathlessness in patients with advanced respiratory 
diseases (30). The movement of cool air with a fan has 
been observed clinically to reduce dyspnoea in respiratory 
patients. Stimulation of mechanoreceptors of the face or 
a decrease in the temperature of the facial skin, both of 
which are mediated through the trigeminal nerve, may alter 
afferent feedback to the brain and modify the perception 
of dyspnoea (32). Data from Cassidy et al. (Monday 17 
September, 8.30–10.30 AM, Room 7.3J) confirms previous 
findings. A hand-held fan was provided to 30 patients, 
mean age 68 years, median time from diagnosis was 
4 years and feedback was given via a 4-point Likert-scale 
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questionnaire to rate the frequency of their breathlessness 
during activities of daily living. All patients agreed/strongly 
agreed that the fan was effective (100%) and easy-to-
use (96.2%), helped improve breathlessness (92%) and 
relaxation (78.3%), and enabled them to concentrate more 
on their breathing (91.3%). The authors concluded that 
healthcare professionals should consider hand-held fans as a 
practical non-pharmacological option for the management 
of dyspnoea in ILD patients. From experience in clinical 
practice, chronic pulmonary patients experiencing an 
exacerbation often have the need to open windows and for a 
consistent flow of air in the room. At their homes, patients 
often use a hand-held fan, ventilation or air conditioner 
to self-manage their dyspnoea. Breathlessness, however, 
impedes the performance of daily activities and patients 
struggle with self-preservation. Instinctively, without 
suggestion of health care professionals patients use this kind 
of methods in management of dyspnoea.
The development of an instrument to assess the needs of 
people with COPD: a Delphi study
The complexity of COPD can negatively impact the lives 
of people and compromises their capacity to take care of 
their needs. Unmet needs can lead to significant morbidity, 
unpleasant emotional experiences and a poor quality of 
life (33). Self-management educational interventions are 
carried out to improve the level of respiratory function 
and therapeutic adherence, and to reduce the occurrence 
of exacerbations (34). The complexity of COPD, which 
results from differences in the evolution of the disease, the 
various therapeutic approaches, frequent exacerbations, 
the lack of home-based management of symptoms, and 
reduced social and family relationships, can have a negative 
impact on the everyday lives of people with the disease and 
compromise their capacity to take care of their needs (35). 
These needs can be defined as being the condition of 
a person being in demand of some necessary, desirable 
or valuable action or support to achieve optimal 
well-being (36). The identification of these needs 
through qualitative evidence can facilitate the creation 
of interventions aimed at identifying specific needs and 
personalising patient care (33). Clari et al. (Monday 17 
September, 8.30–10.30 AM, Room 7.3J) pointed out that 
COPD patient-centred self-management interventions 
firstly have to identify patients’ needs to effectively support 
the patients to positively adapt their health behaviours 
and develop skills to manage their disease better. To our 
knowledge, no tools to measure the needs of people with 
COPD are present in the literature. The aim was to develop 
an instrument to assess the needs of people with COPD. 
Clari et al. used a three-round modified Delphi method to 
develop an instrument to assess the needs of people with 
COPD. After three rounds, a consensus was reached on a 
questionnaire consisting of 25 items distributed across four 
domains: information needs, needs relating to the symptoms 
of the disease, needs of family and social support, and needs 
related to the access to care. The authors concluded that 
the Needs in COPD Assessment questionnaire could be a 
useful tool to detect the needs of people with COPD. This 
tool, which covers a variety of domains, could be an easy to 
use instrument, but a further study is necessary to validate 
its psychometric properties before it can be implemented in 
the clinical context. 
Health status among adult asthmatics—a population-based 
study
Asthma in women is  reported to be more severe 
and associated with higher health care use (37,38). 
Understanding and using strategies that target this gender-
specific difference in disease response and symptom profiles 
may result in improved asthma-related quality of life and 
health of asthmatic women (39). However, other factors 
associated to health have rarely been studied in population-
based samples. Data from Stridsman et al. (Monday 17 
September, 8.30–10.30 AM, Room 7.3J) determined factors 
associated with generic health in a population-based adult 
asthma cohort (the OLIN-studies) in 2012–2014, where 
n=1,425 subjects were invited to a clinical follow-up. 
N=1,006 subjects participated, of which n=830 had current 
asthma. Stridsman et al. described an association between 
worse physical and mental health in adult asthmatics and 
female gender, a higher BMI and health care visits due 
to respiratory symptoms. Eczema was only associated 
with worse mental health, and increasing age and blood 
neutrophils ≥5×109/L with physical health. In addition, 
subjects with allergic asthma seem to have a better physical 
health than those with non-allergic asthma. An important 
reason to monitor health status is that it predicts health care 
utilization among patients who have asthma and for this 
reason it may be a useful method of identifying patients who 
are at risk of exacerbation (40,41). The results of the present 
study indeed confirm that female gender is associated with 
worse asthma control and health status in adult asthmatics. 
Furthermore, to improve the patient’s health status and 
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prognosis BMI and health care visits due to respiratory 
symptoms in the last 12 months should also be taken into 
consideration. The latter factors should be included in 
clinical assessment of health status. In assessment of mental 
health consider the presence of eczema and in physical 
health increasing age and blood neutrophils ≥5×109/L.
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